Stay updated with the Cipla Stock Liveblog, your one-stop destination for real-time information and analysis of a leading ...

The Mumbai-based drugmaker, in a regulatory filing, said it has the rights to distribute and promote Yurpeak, the second anti ...

Track 10 key stocks including IndiGo, LIC, Cipla, and TCS for major news and market updates—see which companies are making ...

Welcome to the Cipla Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most prominent ...

Commenting on the launch, Achin Gupta, Global Chief Operating Officer, Cipla Limited, said, "The launch of Yurpeak marks a transformative moment in the fight against obesity and type 2diabetes ...

Approved by the Drug Controller General of India (DCGI), the treatment offers to slow disease progression and promote cartilage maintenance for patients with Grade II and III knee OA ...

Cipla subsidiary InvaGen issued a voluntary recall of one lot of the oral anti-seizure drug vigabatrin due to problems with seal integrity in its packaging. The recalled lot of the medication, which ...

Cipla has launched India's first integrated Breathefree Lung Wellness Centre in New Delhi, aiming to revolutionize respiratory care. This facility off ...

(Reuters) -Indian drugmaker Cipla said on Thursday its global chief executive and managing director, Umang Vohra, will step down at the end of his term in March after nearly a decade in the top role.

The centre will provide a comprehensive gamut of over 60 tests covering lung physiology, microbiology, immunology, blood chemistry and radiology ...

Cipla and Stempeutics launch Ciplostem, a DCGI-approved cell therapy for Grade II–III Knee Osteoarthritis, offering long-term ...

New Delhi : Pharma major Cipla Ltd on Friday said it will acquire 21.05 per cent stake for Rs 25 crore in Achira Labs Pvt Ltd, which is engaged in development and commercialisation of point of care ...